Media Coverage Archives - NFCR

Media Coverage

Cancer Drug Design Company Associated with Longtime NFCR Support Attracts New Investment

Rasio Therapeutics, a company whose cancer drug research technology was developed and applied in part with funding provided over many years by the National Foundation for Cancer Research to University of Maryland, Baltimore, researcher Curt Civin, has raised additional investment funding....

Read more

NFCR CMO Brian Leyland-Jones Featured in Pancreatic Cancer Risk Overview

Insights from National Foundation for Cancer Research Chief Medical Officer Brian Leyland-Jones, along with such other authoritative sources as Johns Hopkins Medicine, the Mayo Clinic and the U.S. National Cancer Institute, are featured in this Eat This, Not That! overview of pancreatic cancer warning signs....

Read more

Interview with NFCR CEO Sujuan Ba Featured in BioBuzz—a Popular Regional Industry News Source

5 Questions With…” is a weekly BioBuzz series where interesting people share a little about themselves, their work and maybe something completely unrelated. This week the series features Dr. Sujuan Ba, president and chief executive officer of the National Foundation for Cancer Research....

Read more

Understanding the Role of Physical Traits of Cancer on Tumor Growth

To better understand tumor initiation and growth, National Foundation for Cancer Research (NFCR) Fellow Dr. Rakesh Jain and colleagues continue to investigate the role of the physical microenvironment surrounding cancer cells. When a tumor is growing, the tissues that surround the tumor are disrupted physically and biochemically. The outcomes of…...

Read more

Cytokine discovered by NFCR Fellow Paul Fisher holds promise for combating prostate cancer bone metastasis

Published study continues to build evidence that cytokine discovered by NFCR Fellow Paul Fisher holds promise for combating prostate cancer bone metastasis...

Read more

Worldwide burden of cancer attributable to diabetes and high body-mass index

The International Agency for Research on Cancer (IARC) and the World Cancer Research Fund (WCRF) have concluded that there is a causal association between diabetes and high BMI and several types of cancer.  As the prevalence of  these cancer risk factors increases, clinical and public health efforts should focus on identifying…...

Read more

A new study on Gliblastoma supported by NFCR just published

In a press release from Massachusetts General Hospital titled, “Glioma subtypes determine how the dangerous brain tumors spread, evade anti-angiogenic treatment” the research of NFCR Fellow, Rakesh Jain, Ph.D. is highlighted as published online in Cancer Cell in April, 2018. The study describes, “how different molecular subtypes of glioma cells use different strategies…...

Read more